bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
Business Wire•30/09/2026•08:00 ET
0
Whiz Insights
bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
Companies debut federal distribution collaboration to VA leadership, administrators and physicians at NAVREF 2026
Get started
Create a free account to read the full story.